Johnson & Johnson rises despite warning on pandemic costs
Johnson & Johnson (NYSE: JNJ) is among a select group of 16 companies actively working on a vaccine for coronavirus, rushing to be the first with a cure as it battles rivals such as Pfizer, Gilead Sciences, and GlaxoSmithKline. The US medical and consumer goods group said earlier this month only a few days ago…